ABCD’s Diabetic Nephropathy clinical group publishes new guidelines
A newly formed clinical group of diabetes, nephrology and transplantation experts has published evidence-based guidelines for all aspects of managing Post Transplantation Diabetes.
The guidance, which has been endorsed by Diabetes UK, the British Transplant Society and the Royal College of Physicians of London, was authored by a team of 18 diabetologists and nephrologists.
The guidelines offer evidence graded advice, suggestions for areas of research and audit standards.
One of the lead authors Dr Tahseen Chowdhury, who is a diabetologist at the Royal London Hospital, said: “Solid organ transplantation for patients with end organ failure is a well-established, life-saving and life-changing treatment. People with diabetes are particularly prone to developing end stage renal disease, and transplantation is shown to improve quality and quantity of life.
“Among people who do not have diabetes, the development of the condition after solid organ transplantation occurs in 10-40 per cent of recipients, and is a marker for increased mortality and morbidity (including graft loss) after transplantation.”
Dr Adnan Sharif, who is a Nephrologist at the Queen Elizabeth Hospital and was also a lead author, added: “We hope these guidelines will enable clinicians to manage the condition proactively, and will enable researchers to develop protocols to explore the many unanswered questions that remain concerning this important condition.”
To read the guidelines, click here.